Naseem Amin
Chairman at BELLEROPHON THERAPEUTICS, INC.
Net worth: 16 053 $ as of 2024-04-29
Naseem Amin active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Independent Dir/Board Member | 2015-06-28 | - |
| Chairman | 2021-05-25 | - | |
| Director/Board Member | 2015-06-28 | 2021-05-25 | |
| AVADEL PHARMACEUTICALS PLC | Director/Board Member | 2024-05-16 | - |
| Independent Dir/Board Member | 2024-05-16 | - | |
Orphalan SA
 Orphalan SA Pharmaceuticals: MajorHealth Technology GMP-Orphan SA engages in the research and development in biotechnology. It focuses on developing and designing drugs for life-threatening and rare diseases. The company was founded by Frederic Marin on July 18, 2011 and is headquartered in Paris, France. | Director/Board Member | 2016-12-31 | - |
| Chief Executive Officer | 2016-12-31 | - |
Career history of Naseem Amin
Former positions of Naseem Amin
| Companies | Position | Start | End |
|---|---|---|---|
| ARIX BIOSCIENCE PLC | Director/Board Member | 2019-12-16 | 2020-04-05 |
| Chairman | 2020-04-05 | 2021-04-29 | |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 2014-12-31 | 2019-12-30 |
| SMITH & NEPHEW PLC | Chief Tech/Sci/R&D Officer | 2010-11-28 | 2013-12-31 |
| Corporate Officer/Principal | 2010-11-11 | 2010-11-28 | |
Biogen Idec Ltd.
 Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom. | Corporate Officer/Principal | 2004-12-31 | 2008-12-31 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 1998-12-31 | 2004-12-31 |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Sales & Marketing | - | - |
| ░░░░ ░░░░░ ░░░░░░ ░░░░ | ░░░░░░░░ | - | - |
Training of Naseem Amin
| Kellogg School of Management | Masters Business Admin |
| UCL Medical School | Doctorate Degree |
Statistics
International
| United Kingdom | 7 |
| United States | 5 |
| France | 2 |
Operational
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chairman | 3 |
Sectoral
| Health Technology | 8 |
| Consumer Services | 4 |
| Finance | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| SMITH & NEPHEW PLC | Health Technology |
| BELLEROPHON THERAPEUTICS, INC. | Health Technology |
| ARIX BIOSCIENCE PLC | Finance |
| AVADEL PHARMACEUTICALS PLC | Health Technology |
| Private companies | 6 |
|---|---|
Open House London Ltd.
 Open House London Ltd. RestaurantsConsumer Services Open House London Ltd. was founded in 2013 and operates restaurants. The non-profit company is based in London, UK. | Consumer Services |
Biogen Idec Ltd.
Biogen Idec Ltd. BiotechnologyHealth Technology Biogen Idec Ltd. develops therapies for neurodegenerative, haematologic, and autoimmune disorders. The firm develops treatment for Alzheimer’s Disease, spinal muscular atrophy, lupus, and amyotrophic lateral sclerosis (ALS), amongst others. The company was founded on 2003 and is headquartered in Maidenhead, the United Kingdom. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Advent Venture Partners LLP
Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Finance |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Orphalan SA
Orphalan SA Pharmaceuticals: MajorHealth Technology GMP-Orphan SA engages in the research and development in biotechnology. It focuses on developing and designing drugs for life-threatening and rare diseases. The company was founded by Frederic Marin on July 18, 2011 and is headquartered in Paris, France. | Health Technology |
- Stock Market
- Insiders
- Naseem Amin
- Experience
